Invida joins hands with Roche Korea

Published: 2011-02-17 06:57:00

Updated: 2011-02-17 06:57:00

Invida Group Pte Ltd, the leading specialty biopharmaceutical company focusing on the commercialization of healthcare products throughout Asia Pacific, Tuesday announced that it has entered into an agreement with Roche Korea to market Roche’s proprietary products in Korea.

Under this agreement...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK